Related Experiment Video
Updated: Jan 12, 2026
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
cPLA2α-driven Cox-2/PGE2 axis promotes hypoxia-induced senescence in Jurkat T cells
Jae-Ha Jung1, Yeseul Yang2, Yongbaek Kim3
1Laboratory of Clinical Pathology, College of Veterinary Medicine, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea; BK 21 FOUR Program for Future Veterinary Medicine Leading Education and Research Center, College of Veterinary Medicine, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea.
Abstract:
T-cell dysfunction is a critical obstacle to effective anti-cancer immunotherapy. Despite the fact that hypoxia is a common feature of the tumor microenvironment, the mechanisms driving T-cell senescence under hypoxic conditions remain largely unexplored. This study investigated the impact of hypoxic conditions on CD4+ T-cell senescence using Jurkat T cell line. Under hypoxia, T cell exhaustion was not induced; however, senescence-associated β-galactosidase (SA-β-gal) activity and lipid accumulation were increased. Tumor immune estimation resource analysis revealed that PLA2G4A that encodes cPLA2α protein is associated with reduced tumor purity and increased CD4+ T-cell infiltration in various cancers, suggesting a role in immune modulation. Hypoxia-induced activation of cPLA2α promoted lipid accumulation. Inhibition of cPLA2α under hypoxia led to a reduction in SA-β-gal activity and p27 expression, along with decreased levels of cyclin B1 and CDC2, indicative of G2/M cell cycle arrest. Moreover, cPLA2α inhibition restored CD28 expression and suppressed TGF-β1 levels, both of which are associated with T-cell senescence. Hypoxia-induced cPLA2α activation upregulated Cox-2-mediated prostaglandin E2 (PGE2) production, and exogenous PGE2 treatment further increased SA-β-gal activity. These findings illustrated that cPLA2α-driven lipid metabolism under hypoxia contributes to the T-cell senescence and may represent a therapeutic target to enhance anti-cancer immunity.
Insights
Hypoxia promotes T-cell senescence via cPLA2α activation, increasing lipid accumulation and cell cycle arrest. Inhibiting cPLA2α may enhance anti-cancer immunotherapy by restoring T-cell function.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Metabolism
Background:
- T-cell dysfunction hinders anti-cancer immunotherapy effectiveness.
- Tumor hypoxia is common, but its impact on T-cell senescence is poorly understood.
- Understanding hypoxia's role in T-cell senescence is crucial for improving cancer treatments.
Purpose of the Study:
- To investigate the effects of hypoxic conditions on CD4+ T-cell senescence.
- To explore the role of phospholipase A2 group IV A (PLA2G4A) and its encoded protein cPLA2α in hypoxia-induced T-cell senescence.
- To identify potential therapeutic targets for enhancing anti-cancer immunity.
Main Methods:
- Utilized Jurkat T cell line under hypoxic conditions.
- Analyzed senescence markers like SA-β-gal activity, lipid accumulation, and cell cycle regulators (p27, cyclin B1, CDC2).
- Investigated the role of cPLA2α inhibition and its downstream effects on immune markers (CD28, TGF-β1) and prostaglandin E2 (PGE2) production.
Main Results:
- Hypoxia increased SA-β-gal activity and lipid accumulation in T cells, without inducing exhaustion.
- PLA2G4A/cPLA2α activation under hypoxia promoted lipid accumulation and T-cell senescence.
- Inhibiting cPLA2α reduced senescence markers, restored CD28 expression, suppressed TGF-β1, and decreased hypoxia-induced PGE2 production.
Conclusions:
- Hypoxia-induced cPLA2α activation drives T-cell senescence through lipid metabolism and PGE2 production.
- cPLA2α represents a potential therapeutic target to overcome T-cell dysfunction in the tumor microenvironment.
- Targeting cPLA2α may enhance anti-cancer immunotherapy efficacy by rejuvenating T cells.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:31The Intrinsic Apoptotic Pathway
01:24Regulation of Angiogenesis and Blood Supply
02:15Replicative Cell Senescence
02:23Abnormal Proliferation
01:07MAPK Signaling Cascades